Wondering why Hyperrho is so hard to find in 2026? Learn why this Rho(D) immune globulin faces supply issues and what you can do to get your dose.
If you're pregnant and Rh-negative, you already know how important Hyperrho is. So when your doctor's office or pharmacy tells you it's out of stock, it can feel like a punch to the gut. You're not imagining things — Hyperrho has been genuinely difficult to find for many patients across the United States, and the problem has persisted into 2026.
In this article, we'll explain exactly what Hyperrho is, why it's been so hard to get, and — most importantly — what steps you can take right now to find it.
Hyperrho (also known as HyperRHO S/D) is a brand of Rho(D) immune globulin, a medication made from human plasma. It's manufactured by Grifols and is used to prevent a serious condition called Rh sensitization (also known as Rh isoimmunization).
Here's the short version: if you're an Rh-negative mother carrying an Rh-positive baby, your immune system could develop antibodies against your baby's blood cells. This can cause hemolytic disease of the fetus and newborn (HDFN) — a potentially life-threatening condition for the baby. Hyperrho prevents your body from making those antibodies.
Hyperrho is typically given as an intramuscular injection at around 28 weeks of pregnancy and again within 72 hours after delivery. It may also be given after a miscarriage, ectopic pregnancy, amniocentesis, or any event where fetal blood could mix with the mother's blood.
There isn't one single reason — it's a combination of factors that have created a perfect storm for supply problems.
Hyperrho is made from the plasma of Rh-negative donors who have been sensitized to the Rh(D) antigen. This is an extremely specific donor pool. Only about 15% of the population is Rh-negative to begin with, and only a fraction of those individuals qualify as donors for this product. When donor collections drop — as they did during and after the COVID-19 pandemic — the raw material for Hyperrho becomes scarce.
Unlike a pill that can be manufactured in large batches quickly, Hyperrho requires plasma fractionation — a lengthy, multi-step process that can take 7 to 12 months from plasma collection to finished product. Even if demand spikes tomorrow, new supply won't appear for nearly a year.
The market for Rho(D) immune globulin products is small. Only a handful of companies produce them, including Grifols (Hyperrho), Kedrion Biopharma (RhoGAM), Saol Therapeutics (WinRho SDF), and CSL Behring (Rhophylac). When one manufacturer has a disruption, the others can't easily absorb the extra demand.
Rho(D) immune globulin is needed worldwide, not just in the United States. As more countries adopt routine Rh immunoprophylaxis programs, global demand has increased while supply has remained relatively flat.
Don't panic. There are concrete steps you can take right now.
The fastest way to check which pharmacies near you have Hyperrho in stock is to use Medfinder. It's a free tool that shows real-time availability at pharmacies in your area. You can also check out our guide on how to find Hyperrho in stock near you.
If Hyperrho specifically is unavailable, ask your doctor about other Rho(D) immune globulin products like RhoGAM, WinRho SDF, or Rhophylac. These contain the same active ingredient and serve the same purpose. We cover the options in detail in our post on alternatives to Hyperrho.
Large chain pharmacies are often the first to run out because they serve the most patients. Independent pharmacies and hospital-based pharmacies sometimes have stock that isn't visible to the chains' systems.
Many OB-GYN practices keep Hyperrho or other Rho(D) immune globulin products in their office and administer it directly. Your doctor's office may be able to source it through their own medical supply channels, even when retail pharmacies can't.
Grifols, the manufacturer of Hyperrho, may have information about restocking timelines or be able to direct you to a distributor with available supply. Their customer service line can sometimes provide guidance that isn't available through normal channels.
Finding Hyperrho in 2026 can be frustrating, but it's not impossible. The shortage is driven by real supply constraints — not a permanent disappearance of the drug. By using tools like Medfinder, exploring alternative products, and working closely with your healthcare provider, you can get the protection you and your baby need.
Stay informed by checking our Hyperrho shortage update for 2026 for the latest information.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
